首页 文献索引 SCI期刊 AI助手
登录 注册
首页 正文

EMBO molecular medicine. 2025 Apr 10. doi: 10.1038/s44321-025-00233-3 Q19.02024

SOX9-dependent fibrosis drives renal function in nephronophthisis

SOX9依赖性纤维化驱动肾小管萎缩-间质纤维化病的肾脏功能障碍 翻译改进

Maulin Mukeshchandra Patel  1, Vasileios Gerakopoulos  1, Bryan Lettenmaier  1, Eleni Petsouki  1, Kurt A Zimmerman  2, John A Sayer  3  4  5, Leonidas Tsiokas  6

作者单位 +展开

作者单位

  • 1 Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
  • 2 Department of Internal Medicine, Division of Nephrology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
  • 3 Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
  • 4 Renal Services, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
  • 5 NIHR Newcastle Biomedical Research Centre, Newcastle upon Tyne, UK.
  • 6 Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. leonidas-tsiokas@ouhsc.edu.
  • DOI: 10.1038/s44321-025-00233-3 PMID: 40211043

    摘要 中英对照阅读

    Fibrosis is a key feature of a broad spectrum of cystic kidney diseases, especially autosomal recessive kidney disorders such as nephronophthisis (NPHP). However, its contribution to kidney function decline and the underlying molecular mechanism(s) remains unclear. Here, we show that kidney-specific deletion of Fbxw7, the recognition receptor of the SCFFBW7 E3 ubiquitin ligase, results in a juvenile-adult NPHP-like pathology characterized by slow-progressing corticomedullary cysts, tubular degeneration, severe fibrosis, and gradual loss of kidney function. Expression levels of SOX9, a known substrate of FBW7, and WNT4, a potent pro-fibrotic factor and downstream effector of SOX9, were elevated upon loss of FBW7. Heterozygous deletion of Sox9 in compound mutant mice led to the normalization of WNT4 levels, reduced fibrosis, and preservation of kidney function without significant effects on cystic dilatation and tubular degeneration. These data suggest that FBW7-SOX9-WNT4-induced fibrosis drives kidney function decline in NPHP and, possibly, other forms of autosomal recessive kidney disorders.

    Keywords: FBW7; Fibrosis; Kidney Function; Nephronophthisis; SOX9.

    Keywords:SOX9 dependent fibrosis; renal function; nephronophthisis

    纤维化是囊性肾病的一个关键特征,尤其是常染色体隐性肾脏疾病如肾小管萎缩症(NPHP)。然而,它对肾功能下降的贡献及其潜在分子机制仍然不清楚。在这里,我们显示特异性删除Fbxw7(SCFFBW7 E3泛素连接酶的识别受体)会导致青少年-成年型类似NPHP的病理特征,表现为进展缓慢的皮质髓质囊肿、小管退化、严重纤维化和肾功能逐渐丧失。在失去FBW7的情况下,SOX9(已知是FBW7的底物)和WNT4(一种强大的促纤维化因子及SOX9下游效应器)的表达水平升高。复合突变小鼠中的Sox9杂合子删除导致了WNT4水平的正常化、纤维化的减少以及肾功能的保留,而对囊性扩张和小管退化没有显著影响。这些数据表明FBW7-SOX9-WNT4诱导的纤维化驱动NPHP和其他形式的常染色体隐性肾脏疾病的肾功能下降。

    关键词:FBW7;纤维化;肾功能;肾小管萎缩症(Nephronophthisis);SOX9.

    关键词:SOX9依赖性纤维化; 肾功能; 肾小管硬化症

    翻译效果不满意? 用Ai改进或 寻求AI助手帮助 ,对摘要进行重点提炼
    Copyright © EMBO molecular medicine. 中文内容为AI机器翻译,仅供参考!

    相关内容

    期刊名:Embo molecular medicine

    缩写:EMBO MOL MED

    ISSN:1757-4676

    e-ISSN:1757-4684

    IF/分区:9.0/Q1

    文章目录 更多期刊信息

    全文链接
    引文链接
    复制
    已复制!
    推荐内容
    SOX9-dependent fibrosis drives renal function in nephronophthisis